Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.96
10.05.24
-
10.05.25
-4.22%
11.05.24

Could be worthwhile Investment >10% per year
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€3.85
08.05.24
-
08.05.25
-44.13%
09.05.24

Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.21
02.05.24
€10.00
19.02.25
19.26%
05.05.24

buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€4.30
01.05.24
-
01.05.25
-55.79%
10.05.24

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
-0.75%
03.05.24

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.80
29.04.24
€100.00
29.04.25
-2.03%
11.05.24

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€3.96
28.04.24
-
28.04.25
24.79%
11.05.24

Transgene S.A.

Start price
Target price
Perf. (%)
€1.17
27.04.24
€1.00
27.04.25
12.65%
11.05.24

buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€19.90
27.04.24
€20.00
27.04.25
20.60%
11.05.24

buy
Bastide Le Confort

Start price
Target price
Perf. (%)
€17.88
27.04.24
-
27.04.25
8.84%
11.05.24

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.85
25.04.24
-
25.04.25
-1.11%
27.04.24

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-2.00%
27.04.24

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.52
23.04.24
-
23.04.25
-11.36%
28.04.24

Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.68
23.04.24
-
23.04.25
-15.22%
27.04.24

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.50
19.04.24
-
19.04.25
-12.02%
10.05.24

Could be very worthwhile Investment >20% year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€1.31
16.04.24
-
16.04.25
6.59%
27.04.24

buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€1.63
16.04.24
-
16.04.25
-14.11%
28.04.24

Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€62.08
16.04.24
-
22.03.25
14.66%
30.04.24

Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.00
15.04.24
-
15.04.25
11.00%
30.04.24

Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.24
15.04.24
-
12.04.25
12.90%
18.04.24

buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
14.04.24
-
14.04.25
-0.66%
28.04.24

Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.48
12.04.24
-
12.04.25
-16.22%
15.04.24

buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.72
11.04.24
-
11.04.25
-12.21%
14.04.24

Could be worthwhile Investment >10% per year